Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a lifesaving drug, was escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli has resigned as the head of one of the companies he now runs, Turing Pharmaceuticals.
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a lifesaving drug, was escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli has resigned as the head of one of the companies he now runs, Turing Pharmaceuticals. Craig Ruttle The Associated Press
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a lifesaving drug, was escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli has resigned as the head of one of the companies he now runs, Turing Pharmaceuticals. Craig Ruttle The Associated Press

Robert Reich: Martin Shkreli is just one rotten apple in a pair of rotten systems

December 23, 2015 9:00 AM